FDA DrugClass IINotable

FDA Recall: Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured fo

Date: 2026-05-20
Brand: ENDO USA, Inc.
Category: Drug
FDA Class: Class II

Description

Presence of particulate matter: identified as Buprenorphine free base

Hazard

Presence of particulate matter: identified as Buprenorphine free base

Remedy

34,293 vials

View original recall →
Share:

Related Recalls

2026-07-01 · FDA_DRUG
FDA Recall: BD ChloraPrep Clear (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)), 1 mL
CareFusion 213, LLC
2026-07-01 · FDA_DRUG
FDA Recall: Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangared
Annora Pharma Private Limited
2026-07-01 · FDA_DRUG
FDA Recall: BD ChloraPrep FREPP Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)
CareFusion 213, LLC
2026-07-01 · FDA_DRUG
FDA Recall: Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, Rx Only, Amgen Inc., Thousand Oaks, CA 92130
Amgen, Inc.